Speaker
MD, Latigo Biotherapeutics
Neil Singla, Latigo Biotherapeutics, spoke at 20th Annual Pain Therapeutics Summit (Burlingame, United States of America, 28–29 Sept 2026) in the session “Cold Pressor as a Pharmacodynamic Biomarker for NAV 1.8 Development”.
28–29 Sept 2026Burlingame, United States of America
MD, PPD, part of Thermo Fisher
MD, Albany Medical College
Ph.D., National Institute of Neurological Disorders & Stroke, National Institutes of Health
Ph.D., University of California San Francisco
MD, Cenexel
DDS, The Facial Pain Research Association
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Neil Singla, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].